BioCentury
ARTICLE | Clinical News

V.I. Technologies regulatory update

July 6, 1999 7:00 AM UTC

VITX received FDA approval to add to the label claim for its PLAS+SD virus-inactivated plasma that the product has been tested for inactivation of hepatitis A virus. ...